SCHEMBL4093447

SCHEMBL4093447

OC(CBr)Oc1ccccc1

nearest known ligand 0.42

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
LMNA P02545 1/20 0.42
MTNR1A P48039 1/20 0.38
MTNR1B P49286 1/20 0.38
PPARG P37231 6/20 0.37
PPARA Q07869 6/20 0.37
ALDH1A1 P00352 1/20 0.37
RECQL P46063 1/20 0.37
LTA4H P09960 2/20 0.36
TSHR P16473 1/20 0.36
KCNA3 P22001 1/20 0.36
ALOX15 P16050 1/20 0.35
SLC6A4 P31645 1/20 0.35
CA5A P35218 1/20 0.34
CA5B Q9Y2D0 1/20 0.34
L3MBTL1 Q9Y468 1/20 0.34
ADRB2 P07550 1/20 0.34
ADRB1 P08588 1/20 0.34
CYP2D6 P10635 1/20 0.34
ADRB3 P13945 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL242390 0.79 LMNA (0.43) LMNAMTNR1AMTNR1BPPARGPPARA
SCHEMBL19309368 0.79 LMNA (0.43) LMNAMTNR1AMTNR1BPPARGPPARA
SCHEMBL50191 0.77 LMNA (0.47) LMNAMTNR1AMTNR1BPPARGPPARA
SCHEMBL8694787 0.77 LMNA (0.42) LMNAMTNR1AMTNR1BPPARGPPARA
SCHEMBL10358911 0.77 LMNA (0.42) LMNAMTNR1AMTNR1BPPARGPPARA
SCHEMBL194634 0.77 LMNA (0.42) LMNAMTNR1AMTNR1BPPARGPPARA
SCHEMBL8608317 0.77 LMNA (0.42) LMNAMTNR1AMTNR1BPPARGPPARA
SCHEMBL11659888 0.76 TSHR (0.39) LMNAMTNR1AMTNR1BPPARGPPARA
SCHEMBL2569853 0.76 ALDH1A1 (0.45) LMNAMTNR1AMTNR1BPPARGPPARA
SCHEMBL2506181 0.76 LMNA (0.45) LMNAMTNR1AMTNR1BPPARGPPARA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090227543-A1 PHOSPHONATE COMPOUNDS HAVING IMMUNO-MODULATORY ACTIVITY CANNIZZARO CARINA 2009-09-10 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090227543-A1 PHOSPHONATE COMPOUNDS HAVING IMMUNO-MODULATORY ACTIVITY PHOSPHO1, NFATC1, IFNG LMNA 4759/4885MTNR1A 3901/4885MTNR1B 3313/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.